Advanced searches left 3/3

Chromium - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 17 April 2022

* If you want to update the article please login/register

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy Study After Everolimus-eluting Cobalt-chromium Stent-3

However, when DAPT is initiated even in a very short DAPT regimen, the chance of bleeding in patients with elevated blood risk was particularly high within 1-month after percutaneous coronary surgery in previous chort studies. In another trial, prasugrel monotherapy without aspirin was found without thrombosis in selected patients with low risk stable coronary artery disease. Therefore, we've designed a report to compare the cardiovascular and bleeding events in patients with HBR or ACS with no DAPT strategy and a 1-month DAPT plan.

Source link: https://clinicaltrials.gov/ct2/show/NCT04609111

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions